Efficacy and tolerability of peptide receptor radionuclide therapy (PRRT) in advanced metastatic bronchial neuroendocrine tumours (NETs)
Eitan Mirvis, Christos Toumpanakis, Dalvinder Mandair, Gopinath Gnanasegaran, Martyn Caplin, Shaunak Navalkissoor
Topics & Concepts
Radionuclide therapyMedicineNeuroendocrine tumorsTolerabilitySomatostatinProgression-free survivalInternal medicineSomatostatin receptorPeptide receptorOctreotideOncologyChemotherapyAdverse effectReceptorNeuroendocrine Tumor Research AdvancesLung Cancer Research StudiesRadiopharmaceutical Chemistry and Applications